IDEX Aktie

IDEX für 0 Euro bei ZERO ordern (zzgl. Spreads)

WKN: 877444 / ISIN: US45167R1041

<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>
<
Aktion
Portfolio
Watchlist
>
04.02.2026 14:00:29

IDEX Issues FY26 Guidance

(RTTNews) - IDEX (IEX) said its full year 2026 organic sales are projected to increase 1% to 2% over the prior year. Full year adjusted EPS is expected in a range of $8.15 to $8.35. For the first quarter, the company expects organic sales to increase approximately 1%, and adjusted EPS in a range of $1.73 to $1.78.

For the fourth quarter, the company's bottom line totaled $128.3 million, or $1.71 per share. This compares with $123.2 million, or $1.62 per share, last year. Excluding items, IDEX reported adjusted earnings of $157.2 million or $2.10 per share for the period. Revenue rose 4.2% to $899.1 million from $862.9 million last year.

In pre-market trading on NYSE, IDEX shares are down 0.3 percent to $201.00.

For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com.

Analysen zu IDEX Corp.

mehr Analysen
Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

IDEX Corp. 181,15 0,72% IDEX Corp.